Join
Live feed
·
INSIDERFilingvia Quantisnow
SAB Biotherapeutics Inc. logo

Sessa Capital (Master), L.P. converted options into 4,584,571 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SABS· SAB Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SABS (SAB Biotherapeutics Inc.) and more on Quantisnow.

Sessa Capital (Master), L.P. converted options into 4,584,571 shares (SEC Form 4) | Quantisnow